Research Article
[Retracted] Risk Factors for Thyroid Dysfunction in Patients with Advanced Non-Small-Cell Lung Cancer Treated with PD-1 Antibody
Table 4
Correlation analysis of factors of thyroid dysfunction (
±
s, points).
| Project | β | Se | X2 | OR | 95% CI | |
| Female | 0.934 | 0.421 | 4.922 | 2.545 | 1.115–5.808 | 0.027 | Course of disease ≥1 year | 1.024 | 0.471 | 4.727 | 2.784 | 1.106–7.009 | 0.030 | Surgical history | −0.214 | 0.428 | 0.250 | 0.807 | 0.349–1.868 | 0.617 | History of chemotherapy | 0.172 | 0.372 | 0.214 | 1.188 | 0.573–2.462 | 0.644 | History of radiotherapy | 0.119 | 0.513 | 0.054 | 1.126 | 0.412–3.079 | 0.817 | BMI index | −0.121 | 0.631 | 0.037 | 0.886 | 0.257–3.052 | 0.848 | Thyroid nodules | 2.104 | 0.621 | 11.479 | 8.199 | 2.427–27.692 | 0.001 | Baseline TSH level | 0.324 | 0.423 | 0.587 | 1.383 | 0.603–3.168 | 0.444 |
|
|